相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Clinical outcomes of extended versus intermittent administration of piperacillin/tazobactam for the treatment of hospital-acquired pneumonia: a randomized controlled trial
H. Bao et al.
EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES (2017)
Conventional Versus Prolonged Infusion of Meropenem in Neonates With Gram-negative Late-onset Sepsis A Randomized Controlled Trial
Abd Elazeez Shabaan et al.
PEDIATRIC INFECTIOUS DISEASE JOURNAL (2017)
Pharmacokinetic and Pharmacodynamic Efficacies of Continuous versus Intermittent Administration of Meropenem in Patients with Severe Sepsis and Septic Shock: A Prospective Randomized Pilot Study
Hui-Ying Zhao et al.
CHINESE MEDICAL JOURNAL (2017)
Is prolonged infusion of piperacillin/tazobactam and meropenem in critically ill patients associated with improved pharmacokinetic/pharmacodynamic and patient outcomes? An observation from the Defining Antibiotic Levels in Intensive care unit patients (DALI) cohort
Mohd H. Abdul-Aziz et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2016)
Population Pharmacokinetics and Dosing Regimen Optimization of Meropenem in Cerebrospinal Fluid and Plasma in Patients with Meningitis after Neurosurgery
Cheng Lu et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2016)
Population pharmacokinetics and probability of target attainment of meropenem in critically ill patients
Francesca Mattioli et al.
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY (2016)
Beta-Lactam Infusion in Severe Sepsis (BLISS): a prospective, two-centre, open-labelled randomised controlled trial of continuous versus intermittent beta-lactam infusion in critically ill patients with severe sepsis
Mohd H. Abdul-Aziz et al.
INTENSIVE CARE MEDICINE (2016)
Should β-lactam antibiotics be administered by continuous infusion in critically ill patients? A survey of Australia and New Zealand intensive care unit doctors and pharmacists
Menino O. Cotta et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2016)
A Nonparametric Pharmacokinetic Approach to Determine the Optimal Dosing Regimen for 30-Minute and 3-Hour Meropenem Infusions in Critically Ill Patients
Sumith K. Mathew et al.
THERAPEUTIC DRUG MONITORING (2016)
A Multicenter Randomized Trial of Continuous versus Intermittent β-Lactam Infusion in Severe Sepsis
Joel M. Dulhunty et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2015)
Evaluating Outcomes of Alternative Dosing Strategies for Cefepime: A Qualitative Systematic Review
Sarah V. Burgess et al.
ANNALS OF PHARMACOTHERAPY (2015)
Principles of Fluid Management
Oleksa Rewa et al.
CRITICAL CARE CLINICS (2015)
Modelled target attainment after meropenem infusion in patients with severe nosocomial pneumonia: the PROMESSE study
Frederic Frippiat et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2015)
Pharmacokinetics of imipenem in critically ill patients during empirical treatment of nosocomial pneumonia: A comparison of 0.5-h and 3-h infusions
Michal Lips et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2014)
Prolonged infusion versus intermittent boluses of β-lactam antibiotics for treatment of acute infections: a meta-analysis
Jocelyn Teo et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2014)
Pharmacokinetics and pharmacodynamics of extended-infusion piperacillin/tazobactam in adult patients with cystic fibrosis-related acute pulmonary exacerbations
Jill M. Butterfield et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2014)
Effect of meropenem administration in extended infusion on the clinical outcome of febrile neutropenia: a retrospective observational study
Csaba Feher et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2014)
Individualised antibiotic dosing for patients who are critically ill: challenges and potential solutions
Jason A. Roberts et al.
LANCET INFECTIOUS DISEASES (2014)
Stability of Generic Meropenem Solutions for Administration by Continuous Infusion at Normal and Elevated Temperatures
Loretta Franceschi et al.
THERAPEUTIC DRUG MONITORING (2014)
Prolonged Infusion Antibiotics for Suspected Gram-Negative Infections in the ICU: A Before-After Study
Heather M. Arnold et al.
ANNALS OF PHARMACOTHERAPY (2013)
Clinical Outcomes With Extended or Continuous Versus Short-term Intravenous Infusion of Carbapenems and Piperacillin/Tazobactam: A Systematic Review and Meta-analysis
Matthew E. Falagas et al.
CLINICAL INFECTIOUS DISEASES (2013)
Continuous Infusion of Beta-Lactam Antibiotics in Severe Sepsis: A Multicenter Double-Blind, Randomized Controlled Trial
Joel M. Dulhunty et al.
CLINICAL INFECTIOUS DISEASES (2013)
Optimal Doripenem Dosing Simulations in Critically Ill Nosocomial Pneumonia Patients With Obesity, Augmented Renal Clearance, and Decreased Bacterial Susceptibility
Jason A. Roberts et al.
CRITICAL CARE MEDICINE (2013)
Clinical and microbiological efficacy of continuous versus intermittent application of meropenem in critically ill patients: a randomized open-label controlled trial
Ivan Chytra et al.
CRITICAL CARE (2012)
Penetration of Anti-Infective Agents into Pulmonary Epithelial Lining Fluid Focus on Antibacterial Agents
Keith A. Rodvold et al.
CLINICAL PHARMACOKINETICS (2011)
Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement
David Moher et al.
ANNALS OF INTERNAL MEDICINE (2009)
Experience with extended-infusion meropenem in the management of ventilator-associated pneumonia due to multidrug-resistant Acinetobacter baumannii
Donghao Wang
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2009)
Meropenem dosing in critically ill patients with sepsis and without renal dysfunction: intermittent bolus versus continuous administration? Monte Carlo dosing simulations and subcutaneous tissue distribution
Jason A. Roberts et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2009)
Meropenem - A review of its use in the treatment of serious bacterial infections
Claudine M. Baldwin et al.
DRUGS (2008)
Evaluation of area under the inhibitory curve (AUIC) and time above the minimum inhibitory concentration (T>MIC) as predictors of outcome for cefepime and ceftazidime in serious bacterial infections
Peggy S. McKinnon et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2008)
Meropenem by continuous versus intermittent infusion in ventilator-associated pneumonia due to gram-negative bacilli
L Lorente et al.
ANNALS OF PHARMACOTHERAPY (2006)
Antimicrobial pharmacodynamics: Critical interactions of 'bug and drug'
GL Drusano
NATURE REVIEWS MICROBIOLOGY (2004)
分享论文
